- Gives surgeons a noninvasive option to support bone healing following specified cervical fusion procedures
- Designed to support patient compliance through a simple 30-minute, once-daily treatment regimen
Dallas, TX — September 30, 2026 — Enovis™ Corporation (NYSE: ENOV), announced that Spinalogic has received U.S. Food and Drug Administration (FDA) clearance for an expanded indication that includes adjunct use following primary anterior cervical discectomy and fusion (ACDF) surgery of two motion segments, or three vertebrae, from C4–C7 in skeletally mature patients.
The expanded indication extends Spinalogic’s use into cervical fusion, building on its existing indication as an adjunct electrical treatment to primary lumbar spinal fusion surgery for one or two levels. It gives surgeons an additional noninvasive bone growth stimulation option for patients undergoing the specified cervical procedure.
“Achieving a successful fusion is central to what we aim to deliver for our patients,” said Chi Lim*, MD, an orthopaedic spine surgeon at Carolina Orthopaedic & Neurosurgical Associates in South Carolina, whose site contributed data to the real-world evidence study which supported the application. “The expanded indication for Spinalogic gives us an additional noninvasive option to support bone healing following indicated cervical fusion surgery. Expanding the tools available to help patients achieve a solid fusion is a meaningful step forward in their care.”
“This milestone expands where Spinalogic can play a role in spinal fusion care,” said Terry Ross, Group President, Prevention and Recovery at Enovis. “It reflects a focused commitment to bringing physicians more options for the patients they treat, and the innovation and collaboration required to turn that commitment into progress.” Spinalogic delivers noninvasive bone growth stimulation through a 30-minute, once-daily treatment regimen in a lightweight, wearable format designed to support patient compliance. The expanded indication also strengthens Enovis’ ability to support patients across the continuum of spine care, from surgery through to recovery and healing.
Spinalogic is available by prescription only. For more information, visit http://www.enovis.com/spinalogic.
*Dr. Lim is a paid consultant of Enovis.